StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3056% above fair value
$19.59−0.20 (-1.01%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Fortrea cash

Cash and short-term investments held at the end of each period.

Fortrea's cash was $220.60M at Sep 30, 2026. For fiscal 2025 it was $174.60M, up 47.3% from the year before. The highest annual figure on record is $174.60M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$174.60M+47.3%
FY2024Dec 31, 2024$118.50M+9.1%
FY2023Dec 31, 2023$108.60M-1.6%
FY2022Dec 31, 2022$110.40M+16.7%
FY2021Dec 31, 2021$94.60M+17.8%
FY2020Dec 31, 2020$80.30M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$220.60M+68.0%
Q2 FY2026Jun 30, 2026$168.60M+107.6%
Q1 FY2026Mar 31, 2026$147.50M+45.2%
Q4 FY2025Dec 31, 2025$174.60M+47.3%
Q3 FY2025Sep 30, 2025$131.30M+24.7%
Q2 FY2025Jun 30, 2025$81.20M-35.7%
Q1 FY2025Mar 31, 2025$101.60M+9.5%
Q4 FY2024Dec 31, 2024$118.50M+9.1%
Q3 FY2024Sep 30, 2024$105.30M+1.4%
Q2 FY2024Jun 30, 2024$126.20M+15.9%
Q1 FY2024Mar 31, 2024$92.80M-21.5%
Q4 FY2023Dec 31, 2023$108.60M-1.6%
Q3 FY2023Sep 30, 2023$103.80M-3.4%
Q2 FY2023Jun 30, 2023$108.90M+14.0%
Q1 FY2023Mar 31, 2023$118.20M+24.9%
Q4 FY2022Dec 31, 2022$110.40M+37.5%
Q3 FY2022Sep 30, 2022$107.50M–
Q2 FY2022Jun 30, 2022$95.50M–
Q4 FY2021Dec 31, 2021$94.60M–
Q4 FY2020Dec 31, 2020$80.30M–

More Fortrea figures

See a number that looks wrong?